Lifecore Biomedical Inc expected to post a loss of 13 cents a share - Earnings Preview

Lifecore Biomedical

07/04/2023 12:14

* Lifecore Biomedical Inc  LFCR.OQ   LFCR.O  is expected
to show a
fall in quarterly revenue when it reports  results on April 10
(estimated). 
    * The Chaska Minnesota-based  company is expected to report 
a
47.2% decrease in revenue to $27.998 million from $53.07 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lifecore Biomedical
Inc
is for a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $5​, above​ its last closing price of $3.83.
​​​

This summary was machine generated April 7 at 11:14 GMT.  All
figures in US dollars  unless otherwise stated